Injunction Against Pfizer's Exubera Tossed Out
A federal judge dealt healthcare company Novo Nordisk A/S a blow Thursday, denying the company's bid for a preliminary injunction that would have barred sales of Pfizer Inc.'s inhaled insulin product...To view the full article, register now.
Already a subscriber? Click here to view full article